JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catz, C.
Right arrow Articles by Yaffe, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catz, C.
Right arrow Articles by Yaffe, S. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 155, Issue 1, 152-156, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


STRAIN AND AGE VARIATIONS IN HEXOBARBITAL RESPONSE

Charlotte Catz 1 and Sumner J. Yaffe 1

1 Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California

In the neonate, drug toxicity is atrributed to poorly developed hepatic drug-metabolizing ability. The possibility that inheritance of toxic receptivity may differ from that of detoxication capability was investigated. Also, differences in drug metabolism throughout development were studied in three inbred strains of mice. Hexobarbital was injected intraperitoneally in mice of different ages and the two effects measured were: 1) hypnotic (as loss of righting reflex) and 2) lethal (as number of deaths 12 hr after injection) . Hexobarbital metabolism was measured in vitro using liver homogenates as the enzyme source. Distinct differences between the strains were found in both of these parameters. Sleeping time correlated with capacity of the liver to metabolize hexobarbital. The strain which exhibited the least hypnotic effect had the highest lethal effect. A hypothetical explanation relates toxicity to a metabolic product of hexobarbital. The variations in sleeping time between strains, apparently genetically determined, were manifest throughout postnatal development beginning at 1 day of age. Within a given strain the results were also influenced by other factors: sleeping time decreased gradually with age, except for marked decline at 3 weeks of age coincident with weaning and increased physical activity; sleeping times were less in females than in males; in females there was a variation in sleeping time with the estrus cycle.

Submitted on July 27, 1965
Accepted on August 31, 1966




This article has been cited by other articles:


Home page
FAKE JDRHome page
D. J. Rinchuse and J. W. Smudski
Effects of Short-Term and Long-Term Administration of Procaine Hydrochloride and Mepivacaine Hydrochloride on Hexobarbital-Induced Sleeping Times in Mice
Journal of Dental Research, September 1, 1975; 54(5): 926 - 930.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.